Medications

Paxlovid associated with lower risk of hospital admission

A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity ...

Diseases, Conditions, Syndromes

CDC report describes recent trends in prevalence of babesiosis

The prevalence of babesiosis is increasing in certain states, including Maine, New Hampshire, and Vermont, which should now be considered to have endemic transmission, according to research published in the March 17 issue ...

page 1 from 2